Core Viewpoint - Nutex Health, Inc. is set to release its Annual Report for the fiscal year ended December 31, 2025, on March 5, 2026, and will hold an earnings conference call on March 6, 2026, to discuss financial performance and business updates [1]. Company Overview - Nutex Health, Inc. is a physician-led integrated healthcare delivery system with 27 micro hospitals and outpatient departments across 12 states [1]. - The company operates two divisions: a Hospital Division, which includes micro-hospitals and specialty hospitals, and a Population Health Management Division, which manages provider networks [1]. Financial Reporting - The Annual Report on Form 10-K will be filed after market close on March 5, 2026, with a press release summarizing financial results issued on the same day [1]. - The earnings conference call is scheduled for March 6, 2026, at 9:30 a.m. CT, where the company will provide insights into its financial performance [1]. Conference Call Details - Participants can join the conference call by dialing 1-877-407-9208 or 1-201-493-6784 [1]. - A transcript and recording of the call will be available on the company's website under "Investor Materials" following the event [1].

Core Viewpoint - Nutex Health Inc. has announced the reopening of Bayou City ER & Hospital, enhancing healthcare access in Northeast Houston with a state-of-the-art facility designed to provide comprehensive medical services [1][5]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 27 micro hospitals and outpatient departments across 12 states, focusing on primary care and risk-bearing physician networks [1][6]. - The company operates two divisions: a Hospital Division that manages innovative healthcare models and a Population Health Management Division that oversees provider networks [7]. Facility Details - Bayou City ER & Hospital is a 40,000 square foot facility featuring 8 Emergency Room beds and 46 inpatient beds, equipped with advanced imaging technology and a full-service laboratory [2]. - The facility aims to provide 24/7 concierge-level care to the community, emphasizing rapid results and same-day scheduling for medical services [2]. Leadership Insights - Laura Rodriguez, the chief administrative officer, highlighted the reopening as a significant transformation for the facility, aiming to serve the community effectively [3][4]. - Tom Vo, the CEO, emphasized the importance of the hospital's reopening as a milestone for Nutex Health, addressing the growing need for accessible high-quality care in the region [5][6].

Core Insights - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 26 micro hospitals and outpatient departments across 12 states [1][3] - The company will present at the 2026 J.P. Morgan Healthcare Conference from January 12-15 in San Francisco, California [1][2] Company Overview - Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas [2] - The company operates through two divisions: a Hospital Division and a Population Health Management Division [2] - The Hospital Division focuses on innovative healthcare models, including micro-hospitals and specialty hospitals, managing 26 facilities [3] - The Population Health Management Division operates provider networks and offers management and administrative support services to affiliated hospitals and physician groups [3]

Core Viewpoint - Nutex Health Inc. has announced an extension of its stock repurchase program, reflecting the Board's confidence in the company's long-term strategy and commitment to enhancing shareholder value [1][5]. Group 1: Stock Repurchase Program - The original stock repurchase program, announced on August 14, 2025, authorized the repurchase of up to $25.0 million of common stock over a six-month period starting from the filing of the Form 10-Q for the quarter ended June 30, 2025 [2]. - The program has been extended through March 31, 2026, and will be implemented under Rule 10b-18 and a Rule 10b5-1 trading plan, effective around December 4, 2025 [3]. - The purpose of the share repurchase program is to increase shareholder value and offset dilution from additional shares related to stock compensation obligations for under-construction and ramping hospitals [4]. Group 2: Company Overview - Nutex Health Inc., headquartered in Houston, Texas, was founded in 2011 and operates as a healthcare management and operations company with two divisions: Hospital Division and Population Health Management Division [6]. - The Hospital Division owns and operates 25 facilities across 11 states, focusing on innovative healthcare models, including micro-hospitals and specialty hospitals [6]. - The Population Health Management Division operates provider networks such as Independent Physician Associations and provides management and administrative support services to affiliated hospitals and physician groups [7].

Core Insights - Nutex Health Inc. (NUTX) has experienced a successful year in stock performance and financial improvements, primarily due to arbitration wins [1] Company Overview - Nutex Health Inc. operates in healthcare management and operations [1] Financial Performance - The company has shown significant financial improvements over the past year, attributed to successful arbitration outcomes [1]

Core Viewpoint - Nutex Health Inc. is addressing a short seller report from Capybara Research, which appears to be an attempt to create market confusion and profit from a decline in the company's trading price [2][3]. Company Overview - Nutex Health Inc. is headquartered in Houston, Texas, and was founded in 2011. It operates in the healthcare management sector with two main divisions: Hospital Division and Population Health Management Division [4]. - The Hospital Division owns and operates 24 facilities across 11 states, focusing on innovative healthcare models such as micro-hospitals and specialty hospitals [4]. - The Population Health Management Division manages provider networks, including Independent Physician Associations (IPAs), and offers management and administrative support services to affiliated hospitals and physician groups [5].

Core Insights - Nutex Health Inc. reported a significant financial performance for the three and nine months ended September 30, 2025, with a revenue growth of 225% and a record cash balance of $166 million [5][7]. Financial Highlights for Three Months Ended September 30, 2025 - Total revenue reached $267.8 million, a 239.9% increase from $78.8 million in the same period of 2024 [7]. - Hospital division revenue was $260.2 million, up 262.8% from $71.7 million in Q3 2024 [7]. - Net income attributable to Nutex Health was $55.4 million, compared to a net loss of $8.8 million in Q3 2024 [7]. - EBITDA for the quarter was $91.8 million, a 2014% increase from $4.3 million in Q3 2024 [7]. - Adjusted EBITDA was $98.5 million, compared to $9.7 million in Q3 2024 [7]. - Operating income improved to $130.4 million from $9.7 million in the same quarter of 2024 [7]. Financial Highlights for Nine Months Ended September 30, 2025 - Total revenue for the nine months was $723.6 million, a 225.5% increase from $222.3 million in the same period of 2024 [7]. - Net income attributable to Nutex Health was $59.0 million, compared to a net loss of $9.5 million in the first nine months of 2024 [7]. - EBITDA for the nine months was $142.9 million, a 616.4% increase from $19.9 million in the same period of 2024 [7]. - Adjusted EBITDA reached $243.0 million, compared to $16.1 million in the first nine months of 2024 [7]. - Total visits at the Hospital Division increased to 140,074, up 13.9% from 122,944 in the same period of 2024 [7]. Operational Insights - The company has a strong pipeline for future growth, reflecting continued demand for small hospitals across the country [6]. - Approximately 70% of hospital revenue was attributed to higher acuity claims and success through the Independent Dispute Resolution (IDR) process [7]. - The company has maintained a high collection rate of over 80% on legal determinations won through arbitration [7]. Compliance and Governance - Nutex Health has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the timely filing of its Form 10-Q for the period ended June 30, 2025 [9][10].

Core Viewpoint - Nutex Health Inc. reported significant financial growth for the first half of 2025, with a total revenue increase of 217.5% compared to the same period in 2024, highlighting the company's strong performance and growth strategy [8][9]. Financial Highlights for the Three Months Ended June 30, 2025 - Total revenue reached $244.0 million, up 220.7% from $76.1 million in the same period of 2024 [9]. - Operating income improved to $33.7 million from $5.3 million year-over-year, marking a $28.4 million increase [9]. - Net loss attributable to Nutex Health was $17.7 million, which included non-cash stock-based compensation expense of $78.7 million [9]. - Adjusted EBITDA was $71.6 million, compared to $6.8 million for the same period in 2024 [9]. Financial Highlights for the Six Months Ended June 30, 2025 - Total revenue for the first half of 2025 was $455.8 million, an increase of $312.2 million from $143.5 million in the first half of 2024 [9]. - Net income attributable to Nutex Health was $3.5 million, a turnaround from a net loss of $0.7 million in the same period of 2024 [9]. - EBITDA for the first half of 2025 was $51.1 million, up 227.4% from $15.6 million in the first half of 2024 [9]. - Total visits at the Hospital Division increased by 15.5%, totaling 93,842 visits compared to 81,276 in the same period of 2024 [9]. Share Repurchase Program - The Board of Directors authorized a stock repurchase program of up to $25.0 million to enhance shareholder value and offset dilution from stock compensation obligations [4][5]. - The program allows for opportunistic repurchases based on market conditions and the company's financial status [6][10]. Company Overview - Nutex Health operates a physician-led integrated healthcare delivery system with 24 micro hospitals and outpatient departments across 11 states [1][19]. - The company focuses on innovative healthcare models and population health management through its two divisions: Hospital Division and Population Health Management Division [19][20].

Core Insights - Nutex Health Inc. announced restated financial results for Q1 2025, highlighting significant growth in revenue and net income compared to the same period in 2024 [1][2][5] Financial Restatement - The Audit Committee concluded that previously issued financial statements for Q1 2025 required restatement due to non-cash adjustments, resulting in a net increase in liabilities by $19.6 million (4.0%) and a decrease in equity by $19.6 million (7.1%) [2][7] - Net income for Q1 2025 increased by $6.6 million (14.9%) to $21.2 million, with diluted earnings per share rising to $3.33 from $2.56 [2][6] Financial Highlights - Total revenue for Q1 2025 reached $211.8 million, a 214.0% increase from $67.5 million in Q1 2024 [6][8] - EBITDA for Q1 2025 was $51.5 million, up 624.7% from $7.1 million in Q1 2024, while adjusted EBITDA increased to $72.8 million from a loss of $0.4 million [6][8] - Net cash from operating activities was $51.0 million for Q1 2025, reflecting strong operational performance [6][8] Operational Performance - The number of patient visits increased by 20.5% to 48,269 in Q1 2025 compared to 40,068 in Q1 2024, with mature hospitals seeing a 5.3% increase in visits [8] - The company reported a record high gross profit margin of 55.9% and a cash balance of $84.7 million as of March 31, 2025 [5][8] Company Overview - Nutex Health operates 24 micro hospitals and outpatient departments across 11 states, focusing on integrated healthcare delivery [1][19] - The company is structured into two divisions: Hospital Division and Population Health Management Division, providing a range of healthcare services [19][20]

Core Insights - Nutex Health Inc. reported a significant financial turnaround for the fiscal year 2024, with total revenue increasing by 93.8% to $479.9 million compared to $247.6 million in 2023, and net income of $52.1 million compared to a net loss of $45.8 million in the previous year [6][14][17] - The company restated its financial results for the fourth quarter and the entire fiscal year 2024, leading to a net increase in liabilities by $13.4 million (2.9%) and a corresponding decrease in equity by the same amount (6.6%) [4][3] - Adjusted EBITDA for 2024 reached $124.1 million, marking a 1046.1% increase from $10.8 million in 2023, indicating strong operational performance [6][11][22] Financial Performance - Total revenue for the year ended December 31, 2024, was $479.9 million, a 93.8% increase from $247.6 million in 2023 [6][14] - Net income attributable to Nutex Health for 2024 was $52.1 million, compared to a net loss of $45.8 million in 2023 [6][14] - Diluted earnings per share decreased by $0.02 to $9.69 from $9.71, while basic earnings per share also decreased by $0.02 to $10.23 from $10.25 [4][6] Operational Highlights - Total visits at the Hospital Division increased to 168,388 for the year ended December 31, 2024, up 16.9% from 144,058 in 2023 [14] - Revenue from mature hospitals (opened prior to December 31, 2021) increased by 56.6% in 2024 compared to 2023 [14] - Operating income for 2024 was $130.7 million, a significant improvement from an operating loss of $31.8 million in 2023 [14][17] Adjustments and Restatements - The restatement included non-cash adjustments, which had no material effect on key metrics such as revenue, liquidity, and operating cash flow [4][3] - Stock-based compensation expense for the year was $16.6 million, compared to $2.8 million in 2023, with 99% attributed to one-time obligations for under-construction hospitals [14][6] - The company corrected the classification of certain liabilities and reclassified related-party accounts payable balances, impacting the balance sheet structure [7][4] Cash Flow and Liquidity - Net cash from operating activities for the year was $23.2 million, reflecting improved operational efficiency [14][6] - As of December 31, 2024, the company had total assets of $655.3 million, including cash and cash equivalents of $40.6 million [15][14] - The company reported a record high cash balance of $40.6 million, underscoring its financial strength [11][14]